Literature DB >> 10037244

On the origin of circulating thyroglobulin.

J J de Vijlder1, C Ris-Stalpers, T Vulsma.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10037244     DOI： 10.1530/eje.0.1400007

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


× No keyword cloud information.
  6 in total

Review 1.  Thyroglobulin as a biomarker of iodine deficiency: a review.

Authors:  Zheng Feei Ma; Sheila A Skeaff
Journal:  Thyroid       Date:  2014-06-12       Impact factor: 6.568

2.  Serum Thyroglobulin Concentration Is a Weak Marker of Iodine Status in a Pregnant Population with Iodine Deficiency.

Authors:  Eftychia Koukkou; Ioannis Ilias; Irene Mamalis; Georgios G Adonakis; Kostas B Markou
Journal:  Eur Thyroid J       Date:  2016-05-20

3.  Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer.

Authors:  S Lisi; F Menconi; M A Altea; L Agate; E Molinaro; M G Castagna; D Taddei; L Grasso; A Pinchera; R Elisei; M Marinò
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

4.  Thyroglobulin level at week 16 of pregnancy is superior to urinary iodine concentration in revealing preconceptual and first trimester iodine supply.

Authors:  Monika Katko; Andrea Anett Gazso; Ildiko Hircsu; Harjit Pal Bhattoa; Zsuzsanna Molnar; Bela Kovacs; David Andrasi; Janos Aranyosi; Rita Makai; Lajos Veress; Olga Torok; Miklos Bodor; Laszlo Samson; Endre V Nagy
Journal:  Matern Child Nutr       Date:  2017-06-07       Impact factor: 3.092

5.  Assessment of iodine status in children, adults, pregnant women and lactating women in iodine-replete areas of China.

Authors:  Fangang Meng; Rencheng Zhao; Peng Liu; Lixiang Liu; Shoujun Liu
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

6.  Serum thyroglobulin is associated with orbitopathy in Graves' disease.

Authors:  S Khamisi; M Lundqvist; P Emadi; K Almby; Ö Ljunggren; F A Karlsson
Journal:  J Endocrinol Invest       Date:  2021-01-29       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.